Science & evidence
Science-grounded neurofeedback
How we work
Our evidence principles
We hold our clinical work to published standards. These are the commitments that follow from that.
No protocol without a rationale
We do not use a protocol that lacks a published rationale. Every training parameter we select maps back to literature.
The brain map drives the protocol
Our protocols are built from each person's qEEG brain map, not a standard template. Generic protocols are a shortcut we do not take.
Ongoing measurement, not a fixed plan
We review each case with ongoing measurement so the plan can be updated as data comes in. Stale protocols serve no one.
Process over promises
We do not make outcome promises. What we promise is a data-guided process. Research describes populations; the clinic clinician works from that patient's data.
Current with the literature
We keep current with the literature and update our methods when the evidence supports it. This is an ongoing commitment, not a one-time review.
The mechanism
Neuroplasticity and learning
Neuroplasticity is the brain's ability to change its patterns and connections in response to experience. Neurofeedback provides the brain with a real-time signal it can learn from. The extent and durability of that learning is what clinicians and researchers continue to study.
When the brain receives repeated feedback tied to its own electrical activity, stable and efficient patterns can become more automatic over time. This is the proposed mechanism behind lasting effects: not a sedative effect, not a stimulant effect, but a learned regulation.
How much this generalizes beyond the training environment, how long it lasts, and for whom it lasts longest are active research questions. We follow that literature closely.
AAPB / ISNR standards
How evidence is rated
AAPB and ISNR use a five-level scale adapted from American Psychological Association standards for empirically supported treatments. The scale measures study quality and replication, not treatment strength for a specific individual.
Neurofeedback for ADHD has reached Level 4 (Efficacious) in published ratings, with multiple randomized controlled trials and meta-analyses supporting it. Other conditions carry varying ratings. A higher rating means a stronger research base; it does not guarantee a given outcome for any individual.
Ratings are updated as new studies are published. See the ISNR and AAPB websites for current ratings.
Evidence levels 1 → 5 (AAPB/ISNR scale)
- 1
Not empirically supported
No controlled study exists for this application.
- 2
Possibly efficacious
At least one study without a waitlist or active control.
- 3
Probably efficacious
Multiple observational studies or single RCT with methodological limitations.
- 4
Efficacious
Multiple RCTs comparing neurofeedback to a waitlist or sham condition.
- 5
Efficacious and specific
Multiple RCTs demonstrating superiority over an active treatment comparator.
Conditions studied
Key research areas
Neurofeedback has been studied across a range of clinical and performance applications. Below are the areas with the strongest published evidence bases.
- Level 4
ADHD / Attention
The most studied application. Multiple meta-analyses and randomized controlled trials.
- Level 3
PTSD / Post-Trauma
Growing evidence base across clinical and veteran populations.
- Level 3
Anxiety
Multiple controlled studies support alpha and SMR protocols for anxiety reduction.
- Level 3
Depression
Alpha asymmetry protocols appear in published trial reports. See the citations below.
- Level 3
Sleep Disorders
Published work has looked at sleep spindles and slow-wave activity. See the citations below.
- Level 2
Concussion / TBI
Emerging area with controlled pilot studies in mild-to-moderate TBI.
Level badges follow the AAPB/ISNR five-level scale. See the scale above.
Standards bodies
Professional organizations
These organizations set the standards, publish the literature, and credential the practitioners. They are the authoritative sources for current evidence ratings.
Publishes the open-access journal NeuroRegulation. Sets ethical and professional standards for neurofeedback practitioners worldwide. Hosts the primary annual research conference.
isnr.org
Issues the Board Certified in Neurofeedback (BCN) credential, which requires supervised training hours, completed coursework, and a written examination.
bcia.org
Publishes Applied Psychophysiology and Biofeedback. Covers the broader biofeedback field and maintains formal evidence ratings for specific clinical applications.
aapb.org
Primary literature
Representative publications
A selection of frequently cited studies in the neurofeedback literature, grouped by research area. Titles only; we do not characterize findings here. Read the papers directly.
ADHD / Attention
- 1
Arns M, de Ridder S, Strehl U, et al.
Efficacy of neurofeedback treatment in ADHD: the effects on inattention, impulsivity and hyperactivity: a meta-analysis.Clinical EEG and Neuroscience, 2009
- 2
Gevensleben H, Holl B, Albrecht B, et al.
Neurofeedback training in children with ADHD: 6-month follow-up of a randomised controlled trial.European Child & Adolescent Psychiatry, 2010
- 3
Lofthouse N, Arnold LE, Hersch S, et al.
A Review of Neurofeedback Treatment for Pediatric ADHD.Journal of Attention Disorders, 2012
- 4
Cortese S, Ferrin M, Brandeis D, et al.
Neurofeedback for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes from Randomized Controlled Trials.Journal of the American Academy of Child and Adolescent Psychiatry, 2016
- 5
van Doren J, Arns M, Heinrich H, et al.
Sustained effects of neurofeedback in ADHD: a systematic review and meta-analysis.European Child & Adolescent Psychiatry, 2019
- 6
Riesco-Matías P, Yela-Bernabé JR, Crego A, et al.
What Do Meta-Analyses Have to Say About the Efficacy of Neurofeedback Applied to Children With ADHD? Review of Previous Meta-Analyses and a New Meta-Analysis.Journal of Attention Disorders, 2021
PTSD / Post-Trauma
- 7
Panisch LS, Hai AH.
The Effectiveness of Using Neurofeedback in the Treatment of Post-Traumatic Stress Disorder: a Systematic Review.Trauma, Violence, & Abuse, 2020
Anxiety and Depression
- 8
Choi SW, Chi SE, Chung SY, et al.
Is alpha wave neurofeedback effective with randomized clinical trials in depression? A pilot study.Neuropsychobiology, 2011
- 9
Hou Y, et al.
Neurofeedback training improves anxiety trait and depressive symptom in generalized anxiety disorder.Brain and Behavior, 2021
Sleep
- 10
Cortoos A, De Valck E, Arns M, et al.
An exploratory study on the effects of tele-neurofeedback and tele-biofeedback on objective and subjective sleep in patients with primary insomnia.Applied Psychophysiology and Biofeedback, 2010
Cognition and Performance
- 11
Enriquez-Geppert S, Huster RJ, Herrmann CS.
EEG-Neurofeedback as a Tool to Modulate Cognition and Behavior: A Review Tutorial.Frontiers in Human Neuroscience, 2017
- 12
Gruzelier JH.
EEG-neurofeedback for optimising performance. I: A review of cognitive and affective outcome in healthy participants.Neuroscience & Biobehavioral Reviews, 2014
Find full texts on PubMed or The Cochrane Library.
Read the literature
Where to find it
Primary literature is publicly accessible. You do not need a subscription for most of it. These are the canonical databases for neurofeedback research.
- PubMed
pubmed.ncbi.nlm.nih.gov
Abstracts and many full texts for biomedical literature, at no charge. Search 'neurofeedback' or 'EEG biofeedback'.
- The Cochrane Library
cochranelibrary.com
Systematic reviews and meta-analyses with standardized risk-of-bias assessment. The highest methodological standard for evaluating treatment evidence.
- NeuroRegulation
ISNR journal · open access
Open-access journal focused specifically on neurofeedback and neuroregulation. Articles are available to read.
- Applied Psychophysiology and Biofeedback
AAPB journal
Covers clinical and research applications of biofeedback including neurofeedback. Published since 1976.
What we do not claim
This website does not guarantee a specific outcome for any individual. A paper reports what happened in that study group. Your situation is different. Your clinician applies the literature to your data. We will not promise you a result we cannot back with your own measurement.
If you see a neurofeedback provider who promises a specific outcome (a set result in a set number of sessions), ask for the published study that supports that claim. A higher evidence level on the rating scale means a more robust research base across a population. It does not mean the effect will appear for you.
What we offer is a data-guided process with ongoing measurement and the willingness to adjust when the data say so.
Questions about the evidence base?
Monday to Friday, 9:00 am to 5:00 pm. Weekends by appointment.
